EP0857209A4 - - Google Patents

Info

Publication number
EP0857209A4
EP0857209A4 EP95922214A EP95922214A EP0857209A4 EP 0857209 A4 EP0857209 A4 EP 0857209A4 EP 95922214 A EP95922214 A EP 95922214A EP 95922214 A EP95922214 A EP 95922214A EP 0857209 A4 EP0857209 A4 EP 0857209A4
Authority
EP
European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95922214A
Other versions
EP0857209A1 (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of EP0857209A4 publication Critical patent/EP0857209A4/xx
Publication of EP0857209A1 publication Critical patent/EP0857209A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP95922214A 1995-06-05 1995-06-05 Fibroblast growth factor 13 Withdrawn EP0857209A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007108 WO1996039508A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor 13

Publications (2)

Publication Number Publication Date
EP0857209A4 true EP0857209A4 (enrdf_load_stackoverflow) 1998-08-12
EP0857209A1 EP0857209A1 (en) 1998-08-12

Family

ID=22249245

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95922214A Withdrawn EP0857209A1 (en) 1995-06-05 1995-06-05 Fibroblast growth factor 13

Country Status (5)

Country Link
EP (1) EP0857209A1 (enrdf_load_stackoverflow)
JP (1) JPH11507504A (enrdf_load_stackoverflow)
KR (1) KR19990022315A (enrdf_load_stackoverflow)
AU (1) AU702682B2 (enrdf_load_stackoverflow)
WO (1) WO1996039508A1 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728546A (en) 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
US5912327A (en) * 1996-09-30 1999-06-15 Human Genome Sciences, Inc. Method of purifying chemokines from inclusion bodies
EP0942981A1 (en) * 1996-11-27 1999-09-22 Human Genome Sciences, Inc. Fibroblast growth factor-13
ATE296117T1 (de) * 1997-03-07 2005-06-15 Wistar Inst Verwendung von adenoviralen vektoren, die pdgf oder vegf exprimieren, zur heilung von gewebsdefekten und zur induzierung der hypervaskulität in säugergeweben
US6632425B1 (en) 1997-03-20 2003-10-14 Human Genome Sciences, Inc. Chemokine compositions
AU9312198A (en) * 1997-09-17 1999-04-05 Genentech Inc. Genes amplified in tumours, antibodies against the proteins encoded thereby, andtheir use in diagnosis and treatment of cancer
CN1311212A (zh) * 2000-03-02 2001-09-05 上海博德基因开发有限公司 一种新的多肽——人成纤维细胞生长因子14和编码这种多肽的多核苷酸
US7217570B2 (en) 2001-08-23 2007-05-15 The Wistar Institute Of Anatomy And Biology Organotypic intestinal culture and methods of use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071567A2 (en) * 1999-05-06 2000-11-30 Human Genome Sciences, Inc. Fibroblast growth factor 13

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000071567A2 (en) * 1999-05-06 2000-11-30 Human Genome Sciences, Inc. Fibroblast growth factor 13

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
COLIGAN ET AL: "Assays for antibody production.", CURRENT PROTOCOLS IN IMMUNOLOGY, vol. 1, 1994, pages 2.1.1 - 2.3.4 *
DATABASE NCBI [online] NCBI; 2003, retrieved from NCBI accession no. NP_003858 *
GOSPODAROWICZ D.: "Fibroblast growth factors: from genes to clinical applications", CELL BIOLOGY REVIEWS, vol. 25, no. 4, 1991, pages 307 - 314, XP002058994 *
GREENE ET AL: "Identification and characterization of a novel member of the fibroblast growth factor family.", EUROPEAN JOURNAL OF NEUROSCIENCES, vol. 10, 1998, pages 1911 - 1925 *
HARLOW; LANE: "Antibodies, a laboratory manual, INDEX", 1988, COLD SPRING HARBOR LABORATORY *
HARTUNG H. ET AL.: "Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart", MECHANISMS OF DEVELOPMENT, vol. 64, no. 1/02, June 1997 (1997-06-01), pages 31 - 39, XP002051180 *
MASON I.J.: "The ins and outs of fibroblast growth factors", CELL, vol. 78, 26 August 1994 (1994-08-26), pages 547 - 552, XP002058995 *
MIYAMOTO ET AL: "Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast Growth factor family, which as a unique secretion property", MOLECULLAR AND CELLULAR BIOLOGY, vol. 13, no. 7, 1993, pages 4251 - 4259, XP002071233 *
See also references of WO9639508A1 *
SMALLWOD P.M. ET AL.: "Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, vol. 93, September 1996 (1996-09-01), pages 9850 - 9857, XP002058996 *
TANAKA A. ET AL.: "Human androgen-induced growth factor in prostate and breast cancer cells: its molecular cloning and growth properties", FEBS LETTERS, vol. 363, no. 3, 24 April 1995 (1995-04-24), pages 226 - 230, XP002059237 *
YAO ET AL: "Pretreatment with intravenous FGF-13 reduces infarct volume and ameliorates neurological deficits following focal cerebral ischemica in rats.", BRAIN RESEARCH, vol. 818, 1999, pages 140 - 146 *

Also Published As

Publication number Publication date
WO1996039508A1 (en) 1996-12-12
AU702682B2 (en) 1999-03-04
AU2697995A (en) 1996-12-24
JPH11507504A (ja) 1999-07-06
KR19990022315A (ko) 1999-03-25
EP0857209A1 (en) 1998-08-12

Similar Documents

Publication Publication Date Title
BR122012014331A2 (enrdf_load_stackoverflow)
IN186280B (enrdf_load_stackoverflow)
IN187669B (enrdf_load_stackoverflow)
IN188559B (enrdf_load_stackoverflow)
AU1627395A (enrdf_load_stackoverflow)
IN178289B (enrdf_load_stackoverflow)
IN182482B (enrdf_load_stackoverflow)
IN183866B (enrdf_load_stackoverflow)
IN184109B (enrdf_load_stackoverflow)
EP0743438A3 (enrdf_load_stackoverflow)
CN3030760S (enrdf_load_stackoverflow)
CN3031655S (enrdf_load_stackoverflow)
CN3031926S (enrdf_load_stackoverflow)
CN3032332S (enrdf_load_stackoverflow)
CN3032692S (enrdf_load_stackoverflow)
CN3032390S (enrdf_load_stackoverflow)
CN3034591S (enrdf_load_stackoverflow)
CN3032522S (enrdf_load_stackoverflow)
CN3031350S (enrdf_load_stackoverflow)
EP0857209A4 (enrdf_load_stackoverflow)
CN3032568S (enrdf_load_stackoverflow)
CN3031001S (enrdf_load_stackoverflow)
EP0910288A4 (enrdf_load_stackoverflow)
EP0826211A4 (enrdf_load_stackoverflow)
CN3034896S (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19971218

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020822

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060407